X

Gufic Biosciences Ltd. Stock Analysis

Small Cap
Evaluated by 680 users | BSE: 509079 | NSE: GUFICBIO |
Pharmaceuticals & Drugs
Gufic Biosciences Ltd. started its plant biotechnology operation three years ago to produce and supply the high yielding and elite planting material of medicinal and other herbal plants using tissue culture techniques. The first biotechnology product was bixa, a source of natural food colour,...

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Return on Capital Employed 8.44%8.67%8.77%12.55%11.78%12.46%17.54%15.29%18.7%18.78%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 62.771.583.6100123152202246306351
Y-o-Y Gr. Rt.-13.9%16.9%19.8%22.8%23.2%33.4%21.4%24.5%14.8%
Adjusted EPS (Rs.) 0.160.210.180.450.540.560.991.111.942.79
Y-o-Y Gr. Rt.-31.3%-14.3%150%20%3.7%76.8%12.1%74.8%43.8%
Book Value per Share (Rs.) 2.252.382.522.93.393.54.394.836.969.68
Adjusted Net Profit 1.21.71.43.54.14.37.68.615.121.7
Net Op. Cash Flow (Rs. Cr.) 3.815.25.310.911.2-4.3-4.1-4.85.2
Debt to Cash Flow from Ops 4.4918.443.956.623.072.94-9.9-13.72-16.5418.78
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Gufic Biosciences Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales 21.1%23.3%20.2%14.8%
Adjusted EPS 37.4%38.9%41.3%43.8%
Book Value per Share 17.623.430.239.1
Share Price 35.5% 19.7% 4.2% 46.3%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Return on Equity (%) 7.069.197.416.7617.0316.2325.0424.1632.9933.53
Operating Profit Margin (%) 8.288.968.7911.029.789.589.999.3512.6913.11
Net Profit Margin (%) 1.922.311.683.513.362.853.783.514.946.19
Debt to Equity 0.991.041.051.551.271.211.261.521.471.3
Working Capital Days 195204213197192199187190201223
Cash Conversion Cycle 65605650372340678673
Entity Percentage Holding
Promoters 65.75%
Institutions 8.79%
Non-Institutions 25.46%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

The 5-year analysis of Gufic Biosciences Ltd.'s performance infers:

Gufic Biosciences Ltd. earnings have grown by 38.9%, whereas share price has appreciated 19.7% CAGR over the past five years, indicating the company's share price is likely undervalued. However, for specific investment actions please connect with your investment advisor.

We analysed the performance of Gufic Biosciences Ltd. share prices over the last 10 years. Here is what we found out:

Gufic Biosciences Ltd. share price has appreciated 31.1% annually over the past ten years.

Gufic Biosciences Ltd. started its plant biotechnology operation three years ago to produce and supply the high yielding and elite planting material of medicinal and other herbal plants using tissue culture techniques. The first biotechnology product was bixa, a source of natural food colour, for which the company has buy back arrangement with the farmers.

This company has a well developed tissue culture facility for production of 5 million plants per annum. The
Gufic Biosciences Ltd. started its plant biotechnology operation three years ago to produce and supply the high yielding and elite planting material of medicinal and other herbal plants using tissue culture techniques. The first biotechnology product was bixa, a source of natural food colour, for which the company has buy back arrangement with the farmers.

This company has a well developed tissue culture facility for production of 5 million plants per annum. The production unit is made by state of the art technology with six growth rooms, which can house 160000 culture bottles at a time. In the inoculation area, 30 persons can work in one shift. The air-conditioning and air handling system incorporates 5 micron and 0.5 micron filters and are designed for class 10,000 and class 100,000 as per us federal standards 209b. The work stations are however class 100.

The company has two green houses of 800 square meters with evaporative cooling, misting and shading equipment for hardening of tissue culture plants. 
In addition the company has shade houses for hardening of plants at 4 loacations.

With the expertise created in the field of agriculture, over the years, along with the right type of research, Gufic has entered into hybrid vegetable seeds. Gufic seeds deals in all major vegetable seeds namely, tomato, chilli, cabbage, cauliflower, capsicum, coriander, bhendi, bottle gourd, bitter gourd, ridge gourd, brinjal, cucumber and watermelon. It is bringing out varieties/hybrids as per the local demands and preferences for particular characteristics in a crop.

Towards this goal, Gufic seeds has already made arrangements with world class breeders and companies to get excellent seed material for development and promotions. Company commands the association of skilled, accomplished and seasoned professionals in research, production and marketing and we shall be striving to bring to you the best of hybrids and varieties to suit specific requirements on continues basis.

Business area of the company:

Gufic Biosciences Ltd. is engaged in diversified business viz. Pharma, Healthcare, Bio- Technology, Seeds, Herbal etc.

Gufic has entered into hybrid vegetable seeds. Gufic seeds deals in all major vegetable seeds namely, tomato, chilli, cabbage, cauliflower, capsicum, coriander, bhendi, bottle gourd, bitter gourd, ridge gourd, brinjal, cucumber and watermelon.

The company has developed in-house, on line real time computer software for forward planning of production schedule to meet market demands as well as monitoring daily production schedule and generating mis reports.


Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback